Steven Cohen’s Aldeyra Therapeutics ALDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$78.1K Sell
63,465
-90,943
-59% -$145K ﹤0.01% 3697
2026
Q2
$329K Buy
+154,408
New +$265K ﹤0.01% 3348
2026
Q1
– Sell
-94,094
Closed -$487K – 3737
2025
Q4
$487K Buy
+94,094
New +$483K ﹤0.01% 3241
2023
Q2
– Sell
-8,510
Closed -$84.5K – 2124
2023
Q1
$84.5K Buy
+8,510
New +$60.2K ﹤0.01% 1668
2021
Q1
– Sell
-858,270
Closed -$5.89M – 935
2020
Q4
$5.89M Buy
858,270
+216,352
+34% +$1.52M 0.03% 552
2020
Q3
$4.76M Buy
+641,918
New +$4.15M 0.02% 576
2019
Q3
– Sell
-325,000
Closed -$1.95M – 1105
2019
Q2
$1.95M Buy
+325,000
New +$2.45M 0.01% 656

Other funds holding ALDX

Steven Cohen's ALDX Position: Q3 2026 in Review

Steven Cohen reduced its Aldeyra Therapeutics (ALDX) stake by 59% in Q3 2026, selling an estimated $145K and leaving 63,465 shares worth $78.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3697.

Steven Cohen first reported a position in ALDX in Q2 2019 and has held it in 7 quarters since. The position peaked at $5.89M in Q4 2020. 97 funds tracked by Wall St. Rank hold ALDX as of Q3 2026.

  • Steven Cohen held 63,465 shares of Aldeyra Therapeutics worth $78.1K as of Q3 2026.
  • Steven Cohen sold 90,943 Aldeyra Therapeutics shares in Q3 2026, an estimated $145K.
  • Aldeyra Therapeutics made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #3697 holding.
  • Steven Cohen first reported a position in Aldeyra Therapeutics in Q2 2019 and has held it in 7 quarters since.
  • Steven Cohen's Aldeyra Therapeutics position peaked at $5.89M in Q4 2020.
  • 97 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.